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Computational simulations are particularly useful for investigating scientific queries that are difficult (or impossible) to approach with studies performed in human subjects or animal models. Today, this experimental approach has either partly or completely replaced laboratory testing. The computational sequence requires fundamentally three distinct work steps: (1) geometry reconstruction of the study model from medical images, (2) biomechanical simulation (finite element or fluidstructure interaction computation), and (3) interpretation of biomechanical parameters. Computational simulations have gained wider recognition in vascular practice as relates to rupture-risk prediction of abdominal aortic aneurysms (AAA) and the hemodynamic performance of stents and endografts used in the treatment of aortic aneurysms, as explained below.
THRESHOLD FOR AAA REPAIR
According to current clinical practice, a sac diameter 55 mm or rapid growth (5 mm in a 6-month period) are generally accepted as indications for AAA repair in men. 2, 3 However, setting a threshold diameter and a growth rate factor for elective repair in all patients may be overly simplistic. Rupture risk depends significantly on additional parameters, such the sac shape, gender, familial predisposition, hypertension, smoking, and the local inflammation and intraluminal thrombus that render the sac wall weaker and thinner, influencing its growth rate and rupture risk. 4 Consequently, the biomechanical approach evolved to overcome the limitations of the diameter and growth rate criteria.
The only prospective study in the literature comparing the AAA rupture risk evaluation between the maximum diameter and the computationally estimated peak wall stress identified the superiority of the latter. 5 Accordingly, peak wall stress integration into an algorithm of parameters associated with the sac wall strength to estimate the rupture risk index (RRI) has further improved the biomechanical basis of rupture risk prognosis. Until recently, these estimations were addressed T. Christian Gasser is a member of the scientific advisory board of VASCOPS GmbH. The other authors declare no association with any individual, company, or organization having a vested interest in the subject matter/products mentioned in this article.
by highly equipped scientists and researchers, mainly in the academic arena. Therefore, a great step forward was the introduction of the aforementioned parameters in commercially available, validated, user-friendly software, i.e., the A4clinics software (VASCOPS GmbH), which allows a hospital-based clinical operator, after a short training session, to perform the RRI estimation procedure from standard computed tomographic angiography images in 10 to 20 minutes, with proven low intra-and interobserver variabilities. [6] [7] [8] [9] Admittedly, none would deny an endovascular intervention to a patient with a large AAA and a low rupture risk index. However, this biomechanical insight may identify those small AAAs that share a high RRI and, hence, are more prone to rupture than the majority of small AAAs. Thus, selective endovascular management may be justified in these ''highrisk'' small AAAs that could not be identified in the two recent randomized, prospective trials that failed to provide solid evidence favoring endovascular treatment of small AAAs.
10,11

BIOMECHANICAL APPROACH OF AORTIC STENT-GRAFTS: WHAT IS TO BE GAINED?
Computational simulation has provided an insightful view of the hemodynamic behavior of aortic stent-grafts. It was shown that aortic geometry presents curvature, angulations, and tortuosity that influence the magnitude and, most importantly, the direction of displacement forces, which are directed not only caudally, but rather anterolateraly or even cephalad. [12] [13] [14] This has clear implications for modifying the design of endovascular grafts, such as the enhancement of central fixation with suprarenal hooks and barbs or the accommodation of endografts onto the aortic bifurcation, which sustains the greatest percentage of displacement forces. 15 Computational studies can provide significant information on the importance of different geometrical features of endografts (angulation, curvature, tortuosity, length or diameter ratios of the different segments) on the risk of migration, overcoming several difficulties and limitations that clinical comparative studies would encounter in drawing similar conclusions. [16] [17] [18] Indeed, it seems difficult to compare the hemodynamic or clinical performance of different types of endografts between several patient groups, since certain patient-specific factors, e.g., the configuration of the iliac vessels and the level of peripheral occlusive disease, may confound the effect of the endograft's structural differences on limb patency and incidence of migration and endoleaks. [19] [20] [21] [22] Consequently, under this perspective, subtle geometrical models of unusual or complex endograft patterns, such as the cross-limbs configuration [19] [20] [21] and fenestrated 22 designs, respectively, can be computationally examined, preceding or even inspiring large-scale clinical studies on the same issue. More intriguingly, as modeling techniques evolve, finite element analysis can be performed for direct comparisons of the mechanical stresses and strains acting on a number of commerciallyavailable device components under a variety of angulations, depicting potential advantages or drawbacks between them. 23 
INTERPRETING CONCLUSIONS:
WHAT TO KEEP?
Computational simulation comprises a powerful tool to provide valuable information about vascular disease and therapies, as well as insightful comparisons between biomaterials. [23] [24] [25] [26] [27] [28] [29] [30] Undoubtedly, though the computational approach may seem useful, the reproducibility and comparison of the method's results between different studies remain the Achilles' heel of the method, mostly due to the limitations that these models carry with respect to functional parameters (boundary conditions), e.g., pressure, flow, or the mathematical modeling approach used (a computational fluid dynamics approach or a fluid-structure interaction methodology). Differences in model assumptions have been found to be more important to simulation results than differences between patient-specific AAA morphologies. 31 Because the biomechanical behavior of AAA is nonlinear, comparisons between individual morphologies and statistics are valid only when detailed information about preconditions and model assumptions is provided. 32 Another point of criticism is the lack of clinical validation of computational results. Only a few clinical studies have been performed to evaluate, directly or indirectly, the findings from precedent computational simulations with respect to the prognostic role of mechanical stresses in AAA rupture or the performance of endografts. 5, 33 Admittedly, the sophisticated software used in laboratories precludes widespread use by clinicians and, therefore, adaptation and application in the clinical field.
However, despite the criticism, the aforementioned limitations and concerns do not preclude from drawing certain conclusions; rather, the question regards ''what sort of conclusions?'' One of the greatest pitfalls in research is being either overenthusiastic or too skeptical in the interpretation of results. At present, conclusions are limited in the comparative presentation of different geometries between endograft designs. These data suffice only to depict certain theoretical advantages or disadvantages between certain endograft geometries (i.e., neck angulation, length or diameter ratios), confirming previous studies failing to show clear comparative advantages of certain marketed endograft types over others. [34] [35] [36] Simply put, computational studies provide hemodynamic data to support the clinical impression that there are no ideal endografts for all patients; rather, one should focus on each patient's individualized AAA anatomy that is best accommodated by one specific endograft's geometrical patterns over others, leading to individualization of the endograft choice for each case. Apart from their theoretical value, these data can help with development of modified endograft patterns that, for example, take into account the higher stresses in the docking limb zone to enhance relevant stabilizing mechanisms. 37, 38 
FUTURE PERSPECTIVES OF COMPUTATIONAL SIMULATION
The implementation of biomechanical characteristics of AAAs via computational simulations in clinical practice enables the description of an individualized risk of rupture or increased growth rate in small AAAs. Since two recent randomized trials failed to support the tendency for early endovascular treatment in every small AAA (5-5.5 cm), 10, 11 it seems prudent, if not imperative, to revisit this idea by selecting those individuals with small AAAs who present the aforementioned characteristics and are, therefore, expected to benefit the most from early intervention. 39 The key element to this approach is the application of a validated and user-friendly software on a large-scale clinical basis in order to extract clinical results.
Commercially available endograft devices present diversity in technical aspects with respect to design, modularity, stent structure, methods of attaching the fabric to the stent, and fixation modes. Bench testing provides valuable information regarding the ex vivo behavior of an endograft, focusing on material properties. [40] [41] [42] However, these results are restricted to plain, idealized geometries that do not represent the actual patient anatomies, where angulation, curvature, torsion, and tortuosity prevail. Since computational modeling of commercially available devices and components has become feasible, 23 it is anticipated that further research with a combination of bench testing and computational simulations may provide important information regarding hybrid endografts, i.e., combining different components from different manufacturers. This hybrid approach to endovascular management of AAAs is frequently dictated either in patients with small access vessels who need smaller limb profiles from a different manufacturer than the one providing the main stent-graft body or when secondary procedures are mandated after the initial endovascular repair. [43] [44] [45] 
CONCLUSION
Taking into account the scope and limitations discussed above, it seems that computational vascular biomechanics provides a promising framework to address clinical problems, allowing a quantitative integration of patientindividualized information. Although one should be cautious when interpreting the results of computational studies, since these are subject to technical limitations, we believe that it is mostly asking the right question that matters! For the time being, this field is currently dominated by bioengineers, and many computational models focus on purely mechanical aspects, while clinical relevance is not the main priority. Consequently, a close collaboration between bioengineers and clinicians would be essential to further advance the field in order to provide individualized information for evidence-based decisions about risk prediction and endograft selection.
